Made in Wales banner.jpg
Made in Wales thumbnail.jpg

Success for BBI Solutions at the Made in Wales Awards

2 Mins

BBI Solutions is proud to have won the Medical, Life Sciences and Healthcare award at Insider Media’s Made in Wales 2020 Awards.

The Crumlin-based manufacturer and leading supplier of immunodiagnostic reagents was among 49 businesses to be named as finalists in this year’s highly anticipated awards, celebrating the country’s most innovative and dynamic manufacturers.

BBI’s success was revealed in a virtual ceremony on Thursday, 15 April, following a forum hosted by Insider Wales’ Douglas Friedli, which discussed the challenges and opportunities that the Welsh manufacturing industry has faced over the last year.

The award recognised BBI Solutions’ position as a leading expert in immunoassay development and manufacturing services, providing an extensive portfolio of products and technologies to the global diagnostics market.

Selecting BBI Solutions as the winner, the judges noted the company’s response to the coronavirus pandemic including its instrumental role in developing Covid-19 lateral low antibody tests as part of the UK-Rapid Test Consortium, along with Abingdon Health, CIGA Healthcare and Omega Diagnostics, as well as manufacturing services for Avacta’s saliva-based rapid SARS-COV-2 antigen tests. 

Other areas highlighted included BBI Solutions’ specialist knowledge and capabilities in mobile health through their Novarum™ mobile technology, which transforms a smartphone camera into an accurate test reader, as well as the company’s growth through its acquisition of DIARECT AG in June 2020.

To see the ful list of winners please visit

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox